Walgreens Boots Alliance, Inc.

NasdaqGS:WBA Stock Report

Market Cap: US$8.3b

Walgreens Boots Alliance Management

Management criteria checks 1/4

Walgreens Boots Alliance's CEO is Tim Wentworth, appointed in Oct 2023, has a tenure of 1.17 years. total yearly compensation is $13.50M, comprised of 9.6% salary and 90.4% bonuses, including company stock and options. directly owns 0.015% of the company’s shares, worth $1.27M. The average tenure of the management team and the board of directors is 1.2 years and 3.2 years respectively.

Key information

Tim Wentworth

Chief executive officer

US$13.5m

Total compensation

CEO salary percentage9.6%
CEO tenure1.2yrs
CEO ownership0.02%
Management average tenure1.2yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

Walgreens' Rally Sputters Amid Takeover Chatter (Rating Downgrade)

Dec 20

How Investors Should Assess The Potential Walgreens Buyout

Dec 11

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Nov 18

Walgreens Q4: 2 Signs Of A Dividend Trap

Oct 29

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Oct 23

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Walgreens: A Turnaround Stock To Avoid

Oct 15

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Sep 29

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Sep 09
Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Sep 06

Is Walgreens Ready To Rebound?

Aug 23

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Aug 13

Walgreens: A Painful Turnaround Lesson

Aug 02

Walgreens: Here's What Comes Next

Jul 09

Walgreens: Yielding Over 8% Following The Earnings Drop

Jul 02

Walgreens: Beware The Value Trap Ahead Of Earnings

Jun 24

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

May 30

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

May 22

Walgreens: Hold Tight, Let It Turn Around First

May 06

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

May 05
Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08
Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19
Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24
After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

CEO Compensation Analysis

How has Tim Wentworth's remuneration changed compared to Walgreens Boots Alliance's earnings?
DateTotal CompensationSalaryCompany Earnings
Aug 31 2024US$13mUS$1m

-US$9b

Compensation vs Market: Tim's total compensation ($USD13.50M) is above average for companies of similar size in the US market ($USD8.04M).

Compensation vs Earnings: Insufficient data to compare Tim's compensation with company performance.


CEO

Tim Wentworth (64 yo)

1.2yrs

Tenure

US$13,497,004

Compensation

Mr. Timothy C. Wentworth, also known as Tim, served as Director of Ushur, Inc. since February 2022. He served as the Chief Executive Officer of Evernorth at Evernorth Health, Inc. (formerly known as Expres...


Leadership Team

NamePositionTenureCompensationOwnership
Stefano Pessina
Executive Chairman of the Board12.7yrsUS$7.87m0.096%
$ 7.9m
Timothy Wentworth
CEO & Director1.2yrsUS$13.50m0.015%
$ 1.3m
Manmohan Mahajan
Executive VP & Global CFO1.4yrsUS$5.54m0.048%
$ 4.0m
Ornella Barra
Chief Operating Officer of Internationalno dataUS$6.82m0.25%
$ 20.6m
Mary Langowski
Executive VP & President of U.S Healthcareless than a yearUS$6.65mno data
Todd Heckman
Senior VP1.4yrsno data0.0019%
$ 158.5k
Neal Sample
Executive VP & Chief Information Officer1.2yrsno data0.0066%
$ 543.3k
Tiffany Kanaga
Vice President of Global Investor Relationsno datano datano data
Matthew D'Ambrosio
Senior VP and Global Chief Compliance & Ethics Officerno datano datano data
Lanesha Minnix
Executive VP & Global Chief Legal Officerless than a yearno datano data
Elizabeth Burger
Executive VP & Chief Human Resources Officerno datano datano data
Liyue Wu
Head of M&A - Asiano datano datano data

1.2yrs

Average Tenure

53yo

Average Age

Experienced Management: WBA's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Stefano Pessina
Executive Chairman of the Board12.7yrsUS$7.87m0.096%
$ 7.9m
Timothy Wentworth
CEO & Director1.2yrsUS$13.50m0.015%
$ 1.3m
Ginger Graham
Lead Independent Director14.7yrsUS$3.50m0.00025%
$ 20.6k
Valerie Jarrett
Independent Director4.2yrsUS$300.00k0.00052%
$ 42.9k
Nancy Schlichting
Independent Director18.2yrsUS$469.99k0.0024%
$ 202.3k
John Lederer
Independent Director9.7yrsUS$320.00k0.0058%
$ 477.3k
Bryan Hanson
Independent Director2.2yrsUS$299.99k0.0036%
$ 294.8k
Janice Babiak
Independent Director12.7yrsUS$432.50k0.00014%
$ 11.6k
William Shrank
Independent Directorless than a yearno data0.00041%
$ 33.9k
Inderpal Bhandari
Independent Director2.3yrsUS$300.00k0.00035%
$ 28.9k
Thomas Polen
Independent Director1.4yrsUS$149.99k0.0019%
$ 157.7k
Robert Huffines
Independent Directorless than a yearUS$59.89kno data

3.2yrs

Average Tenure

65.5yo

Average Age

Experienced Board: WBA's board of directors are considered experienced (3.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 01:47
End of Day Share Price 2024/12/20 00:00
Earnings2024/08/31
Annual Earnings2024/08/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Walgreens Boots Alliance, Inc. is covered by 48 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher GrajaArgus Research Company
Samuel HudsonAtlantic Equities LLP
Eric ColdwellBaird